Literature DB >> 20139894

Granzymes in age-related cardiovascular and pulmonary diseases.

A Hendel1, P R Hiebert, W A Boivin, S J Williams, D J Granville.   

Abstract

Chronic inflammation is a hallmark of age-related cardiovascular and pulmonary diseases. Granzymes are a family of serine proteases that have been traditionally viewed as initiators of immune-mediated cell death. However, recent findings suggest that the pathophysiological role of granzymes is complex. Emerging functions for granzymes in extracellular matrix degradation, autoimmunity, and inflammation suggests a multifactorial mechanism by which these enzymes are capable of mediating tissue damage. Recent discoveries showing that granzymes can be produced and secreted by nonimmune cells during disease provide an additional layer of intricacy. This review examines the emerging biochemical and clinical evidence pertaining to intracellular and/or extracellular granzymes in the pathogenesis of aging and cardiopulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139894     DOI: 10.1038/cdd.2010.5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  25 in total

Review 1.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

2.  Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.

Authors:  Henry W Murray; Marisa Mitchell-Flack; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

3.  Granzyme B-expressing neutrophils correlate with bacterial load in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.

Authors:  Joshua T Mattila; Pauline Maiello; Tao Sun; Laura E Via; JoAnne L Flynn
Journal:  Cell Microbiol       Date:  2015-03-12       Impact factor: 3.715

4.  Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice.

Authors:  P R Hiebert; D Wu; D J Granville
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

5.  MicroRNA-152 and -181a participate in human dermal fibroblasts senescence acting on cell adhesion and remodeling of the extra-cellular matrix.

Authors:  Mara Mancini; Gaelle Saintigny; Christian Mahé; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Eleonora Candi
Journal:  Aging (Albany NY)       Date:  2012-11       Impact factor: 5.682

6.  Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1.

Authors:  Wendy A Boivin; Marlo Shackleford; Amanda Vanden Hoek; Hongyan Zhao; Tillie L Hackett; Darryl A Knight; David J Granville
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

7.  Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm.

Authors:  L S Ang; W A Boivin; S J Williams; H Zhao; T Abraham; K Carmine-Simmen; B M McManus; R C Bleackley; D J Granville
Journal:  Cell Death Dis       Date:  2011-09-08       Impact factor: 8.469

8.  Granzyme K activates protease-activated receptor-1.

Authors:  Dawn M Cooper; Dmitri V Pechkovsky; Tillie L Hackett; Darryl A Knight; David J Granville
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

Review 9.  Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.

Authors:  Bo Liu; David J Granville; Jonathan Golledge; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

10.  A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.

Authors:  Richard D Antrobus; Patrick J Lillie; Tamara K Berthoud; Alexandra J Spencer; James E McLaren; Kristin Ladell; Teresa Lambe; Anita Milicic; David A Price; Adrian V S Hill; Sarah C Gilbert
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.